KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Acquisitions (2017 - 2022)

Amgen (AMGN) has 10 years of Acquisitions data on record, last reported at $3.8 billion in Q4 2022.

  • For Q4 2022, Acquisitions rose 331.35% year-over-year to $3.8 billion; the TTM value through Dec 2022 reached $4.7 billion, up 425.14%, while the annual FY2025 figure was $53.0 million, N/A changed from the prior year.
  • Acquisitions reached $3.8 billion in Q4 2022 per AMGN's latest filing, up from $890.0 million in the prior quarter.
  • Across five years, Acquisitions topped out at $13.4 billion in Q4 2019 and bottomed at -$197.0 million in Q1 2018.
  • Average Acquisitions over 4 years is $2.6 billion, with a median of $177.0 million recorded in 2019.
  • Peak YoY movement for Acquisitions: crashed 89.47% in 2018, then surged 671900.0% in 2019.
  • A 4-year view of Acquisitions shows it stood at $2.0 million in 2018, then soared by 671900.0% to $13.4 billion in 2019, then crashed by 93.38% to $890.0 million in 2021, then surged by 331.35% to $3.8 billion in 2022.
  • Per Business Quant database, its latest 3 readings for Acquisitions were $3.8 billion in Q4 2022, $890.0 million in Q4 2021, and $13.0 million in Q3 2021.